Description: Selvita S.A. operates as a contract research organization in Poland, rest of Europe, the United States, and internationally. It operates in two segments, Contract Research Organization (CRO) services, and Bioinformatics. The company offers drug discovery services in the areas of assay development and screening, medicinal and synthetic chemistry, computer-aided drug design/ artificial intelligence, structural biology, in vitro/ In Vivo pharmacology, ADME/DMPK and analytical testing. It also provides pharma services in the field of drug testing and bioanalytical analysis, including development and optimization, validation and transfer, stability studies, quality control, and regulatory aspects support services. In addition, the company offers research and development services in the areas of process research, laboratory scale custom synthesis of NCEs, industrial chemistry, and synthesis of isotopically labelled compounds, as well as other services for the agrochemical industry. Further, it provides bio-data science and advanced software services to data-driven life science and healthcare organizations. Selvita S.A. was founded in 2007 and is headquartered in Krakow, Poland.
Home Page: selvita.com
ul. Bobrzynskiego 14
Kraków,
30-348
Poland
Phone:
48 122 97 47 00
Officers
Name | Title |
---|---|
Mr. Boguslaw Stanislaw Sieczkowski M.B.A. | Chairman of Management Board & CEO |
Dr. Milosz Kazimierz Gruca Ph.D. | Chief Commercial Officer, Exec. VP & VP of Management Board |
Mr. Dariusz Tomasz Kurdas | Chief Financial Officer & Member of the Management Board |
Dr. Miroslawa Monika Zydron Ph.D. | COO & Member of the Management Board |
Mr. Dawid Patryk Radziszewski | Gen. Counsel & Member of the Management Board |
Dr. Adrijana Vinter | Global Head of Drug Discovery & Member of the Management Board |
Exchange: WAR
Country: PL : Poland
Currency: Polish złoty (zł)
Forward PE: | 0 |
---|---|
Trailing PE: | 62.5899 |
Price-to-Book MRQ: | 6.0986 |
Price-to-Sales TTM: | 3.7349 |
IPO Date: | |
Fiscal Year End: | December |
Full Time Employees: | 878 |